Cipher Pharmaceuticals Stock Price on May 9, 2024
| CPH Stock | CAD 15.35 0.36 2.40% |
Below is the normalized historical share price chart for Cipher Pharmaceuticals extending back to February 25, 2004. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Cipher Pharmaceuticals stands at 15.35, as last reported on the 30th of November, with the highest price reaching 15.35 and the lowest price hitting 14.81 during the day.
If you're considering investing in Cipher Stock, it is important to understand the factors that can impact its price. Cipher Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.044, which signifies that the company had a -0.044% return per unit of risk over the last 3 months. Cipher Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Cipher Pharmaceuticals' Risk Adjusted Performance of (0.02), standard deviation of 3.98, and Mean Deviation of 2.85 to double-check the risk estimate we provide.
At this time, Cipher Pharmaceuticals' Total Stockholder Equity is very stable compared to the past year. As of the 30th of November 2024, Common Stock Shares Outstanding is likely to grow to about 32.1 M, while Liabilities And Stockholders Equity is likely to drop about 46.4 M. . At this time, Cipher Pharmaceuticals' Price Earnings To Growth Ratio is very stable compared to the past year. As of the 30th of November 2024, Price To Operating Cash Flows Ratio is likely to grow to 6.98, while Price To Sales Ratio is likely to drop 4.78. Cipher Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
200 Day MA 11.386 | 50 Day MA 15.2082 | Beta 1.174 |
Cipher |
Sharpe Ratio = -0.044
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CPH |
Estimated Market Risk
| 3.95 actual daily | 35 65% of assets are more volatile |
Expected Return
| -0.17 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.04 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Cipher Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cipher Pharmaceuticals by adding Cipher Pharmaceuticals to a well-diversified portfolio.
Price Book 2.8362 | Enterprise Value Ebitda 25.1441 | Price Sales 14.8444 | Shares Float 14.5 M | Wall Street Target Price 16.7 |
Related Headline
Knight Therapeutics Headline on 9th of May 2024
Knight Therapeutics Announces Q1 Growth and Expansion - TipR... by news.google.com
Knight Therapeutics Announces Q1 Growth and Expansion - TipRanks.com TipRanks
Cipher Pharmaceuticals Valuation on May 9, 2024
It is possible to determine the worth of Cipher Pharmaceuticals on a given historical date. On May 9, 2024 Cipher was worth 9.14 at the beginning of the trading date compared to the closed value of 8.95. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Cipher Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Cipher Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Cipher Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Cipher Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 9.24 | 9.27 | 8.86 | 9.13 | 21,500 | |
05/09/2024 | 9.14 | 9.14 | 8.89 | 8.95 | 15,800 |
| 9.44 | 10.33 | 9.16 | 9.25 | 94,500 |
| Backtest Cipher Pharmaceuticals | | | Cipher Pharmaceuticals History | | | Cipher Pharmaceuticals Valuation | Previous | Next |
Cipher Pharmaceuticals Trading Date Momentum on May 9, 2024
| On May 10 2024 Cipher Pharmaceuticals was traded for 9.25 at the closing time. The maximum traded price for the trading interval was 10.33 and the lowest daily price was 9.16 . The daily volume was recorded at 94.5 K. The volume of trading on 10th of May 2024 played a part in the next trading day price boost. The overall trading delta to the next closing price was 3.35% . The overall trading delta to the closing price today is 1.56% . |
Cipher Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Cipher Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Cipher Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Cipher financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Cipher Pharmaceuticals Stock history
Cipher Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cipher is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cipher Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cipher Pharmaceuticals stock prices may prove useful in developing a viable investing in Cipher Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 25.4 M | 32.1 M | |
| Net Income Applicable To Common Shares | 30.6 M | 32.2 M |
Cipher Pharmaceuticals Quarterly Net Working Capital |
|
Cipher Pharmaceuticals Stock Technical Analysis
Cipher Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Cipher Pharmaceuticals Period Price Range
Low | November 30, 2024
| High |
0.00 | 0.00 |
Cipher Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on Toronto Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Cipher Pharmaceuticals November 30, 2024 Market Strength
Market strength indicators help investors to evaluate how Cipher Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cipher Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Cipher Pharmaceuticals stock market strength indicators, traders can identify Cipher Pharmaceuticals entry and exit signals to maximize returns
Cipher Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Cipher Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Cipher Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cipher to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.17) | |||
| Total Risk Alpha | (0.81) | |||
| Treynor Ratio | (0.99) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Other Information on Investing in Cipher Stock
Cipher Pharmaceuticals financial ratios help investors to determine whether Cipher Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cipher with respect to the benefits of owning Cipher Pharmaceuticals security.